It's not surprising that drug makers oppose Maryland's efforts to limit prices of some prescription drugs, write Sean Tunis ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Speaking outside Sangareddy prison on Friday after meeting 16 arrested villagers, Rama Rao alleged that the arrests were ...

I have spent my career fighting for the hardworking people of our state—especially those who need our support the most.

Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

KKR & Co. is considering selling some of its controlling stake in JB Chemicals & Pharmaceuticals Ltd. via a block trade in ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Private equity group CVC Capital ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

Incyte filed a lawsuit to try to block the launch of Leqselvi, claiming that the drug infringed a US patent (No. 9,662,335) ...

Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most ...